NFKB1 and atherosclerosis: Joint pathway analysis integrating reversed metabolites with predicted targets consistently prioritized Lipid and atherosclerosis, PPAR-related metabolic regulation, PI3K-Akt/eNOS-associated vascular protection, and inflammation-related signaling (JAK-STAT and TNF/NF-κB).